Hjem › Diffust stort B-celle lymfom › Californien › Los Angeles
Diffust stort B-celle lymfom kliniske forsøg i Los Angeles, CA
17 studier for Diffust stort B-celle lymfom søger deltagere på steder i og omkring Los Angeles (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekruttererFase 2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RekruttererFase 2
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruttererFase 3
- Cedars-Sinai Medical Center ( Site 0115), Los Angeles
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
RekruttererFase 3
- David Geffen School of Medicine at UCLA, Los Angeles
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Children's Hospital Los Angeles ( Site 1006), Los Angeles
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
RekruttererFase 2
- Valkyrie Clinical Trials, Los Angeles
A Study of ARC-02 in B-cell NHL
RekruttererFase 1
- Start Cala, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
RekruttererFase 1
- Cedars-Sinai Medical Center, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruttererFase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA), Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
RekruttererFase 1
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekruttererFase 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
RekruttererFase 1/2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RekruttererFase 2
- Cedars Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- University of Southern California, Los Angeles
Diffust stort B-celle lymfom forsøg i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
- Seattle, WA12 studier
Andre studier i Los Angeles
- Ikke-småcellet lungecancer87 studier
- Kræft (alle typer)73 studier
- Brystkræft72 studier
- Prostatakræft61 studier
- Colorektal kræft59 studier
- Metastatisk cancer57 studier
- Ægstockræft50 studier
- Lungecancer45 studier
- Pladecellekræft i hoved og hals42 studier
- Bugspytkirtelkræft35 studier
- Livmoderslimhindekræft34 studier
- Melanom34 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.